New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - capecitabine 150mg;  ;   - film coated tablet - 150 mg - active: capecitabine 150mg     excipient: croscarmellose sodium hypromellose   iron oxide red iron oxide yellow lactose magnesium stearate microcrystalline cellulose purified talc purified water titanium dioxide - capecitabine viatris tablets in combination with docetaxel is indicated for the treatment of patients with locally-advanced or metastatic breast cancer after failure of prior anthracycline-containing chemotherapy. capecitabine viatris tablets as monotherapy is indicated for the treatment of patients with locally-advanced or metastatic breast cancer after failure of both a taxane-containing and anthracycline-containing chemotherapy or in whom taxane-containing and anthracycline-containing therapy are not indicated.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - capecitabine 500mg;  ;   - film coated tablet - 500 mg - active: capecitabine 500mg     excipient: croscarmellose sodium hypromellose   iron oxide red iron oxide yellow lactose magnesium stearate microcrystalline cellulose purified talc purified water titanium dioxide - capecitabine viatris tablets in combination with docetaxel is indicated for the treatment of patients with locally-advanced or metastatic breast cancer after failure of prior anthracycline-containing chemotherapy. capecitabine viatris tablets as monotherapy is indicated for the treatment of patients with locally-advanced or metastatic breast cancer after failure of both a taxane-containing and anthracycline-containing chemotherapy or in whom taxane-containing and anthracycline-containing therapy are not indicated.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - zoledronic acid monohydrate 0.8528 mg/ml equivalent to zoledronic acid 0.8 mg/ml;   - concentrate for infusion - 4 mg/5ml - active: zoledronic acid monohydrate 0.8528 mg/ml equivalent to zoledronic acid 0.8 mg/ml   excipient: hydrochloric acid sodium citrate sodium hydroxide water for injection - · treatment of tumour-induced hypercalcaemia.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - bisoprolol fumarate 10mg - film coated tablet - 10 mg - active: bisoprolol fumarate 10mg excipient: colloidal silicon dioxide croscarmellose sodium stear-o-wet m or ligamed mf bls-mb (magnesium stearate/sodium lauryl sulphate (94/6)) iron oxide red lactose microcrystalline cellulose opadry orange 40c83047 - treatment of stable chronic heart failure with reduced systolic left ventricular function in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - bisoprolol fumarate 2.5mg - film coated tablet - 2.5 mg - active: bisoprolol fumarate 2.5mg excipient: colloidal silicon dioxide croscarmellose sodium stear-o-wet m or ligamed mf bls-mb (magnesium stearate/sodium lauryl sulphate (94/6)) iron oxide red iron oxide yellow lactose microcrystalline cellulose opadry grey 40c57557 - treatment of stable chronic heart failure with reduced systolic left ventricular function in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - bisoprolol fumarate 5mg - film coated tablet - 5 mg - active: bisoprolol fumarate 5mg excipient: colloidal silicon dioxide croscarmellose sodium stear-o-wet m or ligamed mf bls-mb (magnesium stearate/sodium lauryl sulphate (94/6)) iron oxide yellow lactose microcrystalline cellulose opadry yellow 40c82321 - treatment of stable chronic heart failure with reduced systolic left ventricular function in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.

Ireland - English - HPRA (Health Products Regulatory Authority)

viatris limited - amlodipine besilate - tablet - dihydropyridine derivatives; amlodipine

Ireland - English - HPRA (Health Products Regulatory Authority)

viatris limited - amlodipine besilate - tablet - dihydropyridine derivatives; amlodipine

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - atenolol 100mg; atenolol 100mg - film coated tablet - 100 mg - active: atenolol 100mg excipient: colloidal silicon dioxide hypromellose macrogol 6000 magnesium carbonate magnesium stearate maize starch purified talc sodium laurilsulfate sodium starch glycolate sunset yellow aluminium lake titanium dioxide active: atenolol 100mg excipient: colloidal silicon dioxide hypromellose macrogol 6000 magnesium carbonate magnesium stearate maize starch purified talc purified water sodium laurilsulfate sodium starch glycolate titanium dioxide - control of hypertension.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - atenolol 50mg; atenolol 50mg - film coated tablet - 50 mg - active: atenolol 50mg excipient: colloidal silicon dioxide hypromellose macrogol 6000 magnesium carbonate magnesium stearate maize starch purified talc sodium laurilsulfate sodium starch glycolate sunset yellow aluminium lake titanium dioxide active: atenolol 50mg excipient: colloidal silicon dioxide hypromellose macrogol 6000 magnesium carbonate magnesium stearate maize starch purified talc purified water sodium laurilsulfate sodium starch glycolate titanium dioxide - control of hypertension.